From CorInnova, we have CEO William Altman providing an update on the progress of the company’s cardiac medical device to treat heart failure, which has a $6 billion addressable market. CorInnova has raised over $1M from Keiretsu Forum members and is closing out its last angel round as the company has selected an investment banking firm to lead an institutional fund-raise.